Victory Capital Management
IDYA icon

Victory Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Victory Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.27M Sell
137,222
-14,158
-9% -$534K ﹤0.01% 1359
2026
Q2 		$5.64M Sell
151,380
-5,890
-4% -$180K ﹤0.01% 1330
2026
Q1 		$5.24M Sell
157,270
-6,137
-4% -$206K ﹤0.01% 1310
2025
Q4 		$5.65M Sell
163,407
-65,482
-29% -$2.09M ﹤0.01% 1262
2025
Q3 		$6.23M Buy
228,889
+145,601
+175% +$3.52M ﹤0.01% 1259
2025
Q2 		$1.75M Buy
83,288
+39,988
+92% +$767K ﹤0.01% 1632
2025
Q1 		$709K Sell
43,300
-297,763
-87% -$6.34M ﹤0.01% 1937
2024
Q4 		$8.77M Buy
341,063
+27,806
+9% +$787K 0.01% 1120
2024
Q3 		$9.9M Sell
313,257
-2,848
-0.9% -$108K 0.01% 1111
2024
Q2 		$11.1M Buy
316,105
+29,600
+10% +$1.17M 0.01% 1046
2024
Q1 		$12.6M Sell
286,505
-59,985
-17% -$2.58M 0.01% 989
2023
Q4 		$12.3M Buy
+346,490
New +$10.3M 0.01% 967
2023
Q2 		– Sell
-30,700
Closed -$422K – 2554
2023
Q1 		$422K Buy
+30,700
New +$511K ﹤0.01% 2045
2022
Q3 		– Sell
-23,083
Closed -$319K – 2733
2022
Q2 		$319K Sell
23,083
-12,537
-35% -$139K ﹤0.01% 2215
2022
Q1 		$342K Buy
35,620
+18,792
+112% +$277K ﹤0.01% 2253
2021
Q4 		$398K Buy
+16,828
New +$391K ﹤0.01% 2274
2020
Q2 		– Sell
-1,958
Closed -$8K – 2854
2020
Q1 		$8K Buy
+1,958
New +$13.9K ﹤0.01% 3153
2019
Q4 		– Sell
-146,780
Closed -$1.32M – 2922
2019
Q3 		$1.32M Buy
146,780
+900
+0.6% +$6.87K ﹤0.01% 1621
2019
Q2 		$1.45M Buy
+145,880
New +$1.59M ﹤0.01% 1218

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

Victory Capital Management's IDYA Position: Q3 2026 in Review

Victory Capital Management reduced its IDEAYA Biosciences (IDYA) stake by 9.4% in Q3 2026, selling an estimated $534K and leaving 137,222 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1359.

Victory Capital Management first reported a position in IDYA in Q2 2019 and has held it in 19 quarters since. The position peaked at $12.6M in Q1 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Victory Capital Management held 137,222 shares of IDEAYA Biosciences worth $5.27M as of Q3 2026.
  • Victory Capital Management sold 14,158 IDEAYA Biosciences shares in Q3 2026, an estimated $534K.
  • IDEAYA Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1359 holding.
  • Victory Capital Management first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 19 quarters since.
  • Victory Capital Management's IDEAYA Biosciences position peaked at $12.6M in Q1 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.